Format

Send to

Choose Destination
Oncotarget. 2015 Jul 20;6(20):17938-57.

Transcriptional profiling of interleukin-2-primed human adipose derived mesenchymal stem cells revealed dramatic changes in stem cells response imposed by replicative senescence.

Author information

1
Department of Pediatrics, Renmin Hospital of Wuhan University, Wuhan, China.
2
S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
3
School of Biology, Georgia Institute of Technology, Atlanta, GA, USA.
4
Cardiac Development and Repair Department, National Center for Cardiovascular Research (CNIC), Madrid, Spain.
5
PanAmerican Bioinformatics Institute, Santa Marta, Magdalena, Colombia.
6
Aelan Cell Technologies, Inc, San Francisco, CA, USA.

Abstract

Inflammation is a double-edged sword with both detrimental and beneficial consequences. Understanding of the mechanisms of crosstalk between the inflammatory milieu and human adult mesenchymal stem cells is an important basis for clinical efforts. Here, we investigate changes in the transcriptional response of human adipose-derived stem cells to physiologically relevant levels of IL-2 (IL-2 priming) upon replicative senescence. Our data suggest that replicative senescence might dramatically impede human mesenchymal stem cell (MSC) function via global transcriptional deregulation in response to IL-2. We uncovered a novel senescence-associated transcriptional signature in human adipose-derived MSCs hADSCs after exposure to pro-inflammatory environment: significant enhancement of the expression of the genes encoding potent growth factors and cytokines with anti-inflammatory and migration-promoting properties, as well as genes encoding angiogenic and anti-apoptotic promoting factors, all of which could participate in the establishment of a unique microenvironment. We observed transcriptional up-regulation of critical components of the nitric oxide synthase pathway (iNOS) in hADSCs upon replicative senescence suggesting, that senescent stem cells can acquire metastasis-promoting properties via stem cell-mediated immunosuppression. Our study highlights the importance of age as a factor when designing cell-based or pharmacological therapies for older patients and predicts measurable biomarkers characteristic of an environment that is conducive to cancer cells invasiveness and metastasis.

KEYWORDS:

Gerotarget; IL-2; aging; cancer; immunomodulation; mesenchymal stem cells

PMID:
26255627
PMCID:
PMC4627227
DOI:
10.18632/oncotarget.4852
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center